Jazz Pharmaceuticals PLC
(NAS:JAZZ)
$
121.58
-0.01 (-0.01%)
Market Cap: 7.35 Bil
Enterprise Value: 10.93 Bil
PE Ratio: 17.12
PB Ratio: 1.76
GF Score: 85/100 Jazz Pharmaceuticals PLC at Cowen and Company Health Care Conference Transcript
Mar 12, 2019 / 04:00PM GMT
Release Date Price:
$133.85
(+0.64%)
Kenneth Charles Cacciatore
Cowen and Company, LLC, Research Division - MD and Senior Research Analyst
Okay. Thanks, everyone. I appreciate Matt and Kathee coming all the way from the West Coast to join us. So thanks again for doing this. We're really, really appreciative. And so I don't know if you wanted to start with any introductory comments, or we can just get into Q&A. And anyone in the audience, obviously, just raise your hand during it and we'll let you chime in as well.
Matthew P. Young
Jazz Pharmaceuticals plc - Executive VP & CFO
I don't know, Ken, do you have enough questions for us?
Kenneth Charles Cacciatore
Cowen and Company, LLC, Research Division - MD and Senior Research Analyst
I've got questions. If you want to, we'll just get into it.
Matthew P. Young
Jazz Pharmaceuticals plc - Executive VP & CFO
Sure. Yes. Very good.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot